Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AHRQ poses questions on sleep apnea

This article was originally published in The Gray Sheet

Executive Summary

Agency for Healthcare Research and Quality circulates six questions Oct. 7 on the comparative effectiveness of diagnosis and treatment of obstructive sleep apnea. AHRQ seeks public comments on: how the various available tests compare for diagnosing sleep apnea in adults with symptoms suggestive of disordered sleep; how phased testing compares with full testing alone; what the effect of pre-operative screening for sleep apnea is on surgical outcomes; the comparative effects of various sleep apnea treatments; the pre-treatment patient-level characteristics associated with failure to treat obstructive sleep apnea; and the effect of interventions to improve compliance with sleep apnea treatment devices on clinical outcomes

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028010

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel